Related references
Note: Only part of the references are listed.Functional Changes in Myeloid-Derived Suppressor Cells (MDSCs) during Tumor Growth: FKBP51 Contributes to the Regulation of the Immunosuppressive Function of MDSCs
Yun-Sun Kim et al.
JOURNAL OF IMMUNOLOGY (2012)
miR-223 suppresses differentiation of tumor-induced CD11b+Gr1+myeloid-derived suppressor cells from bone marrow cells
Qiaofei Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
The birth of the osteoclast
T. J. Chambers
SKELETAL BIOLOGY AND MEDICINE (2010)
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Minu K. Srivastava et al.
CANCER RESEARCH (2010)
Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound
Jonathan R. Green et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
A murine model of myeloma that allows genetic manipulation of the host microenvironment
Jessica A. Fowler et al.
DISEASE MODELS & MECHANISMS (2009)
Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
Lauren K. Dunn et al.
PLOS ONE (2009)
First thalidomide clinical trial in multiple myeloma: a decade later
Frits van Rhee et al.
BLOOD (2008)
The pathogenesis of the bone disease of multiple myeloma
Claire M. Edwards et al.
BONE (2008)
Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation
Susanne Granholm et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Tumor-induced CD11b(+)Gr-1(+) myeloid cells suppress T cell Sensitization in tumor-draining lymph nodes
Satoshi Watanabe et al.
JOURNAL OF IMMUNOLOGY (2008)
Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo
Claire M. Edwards et al.
BLOOD (2008)
Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2007)
MyD88-dependent expansion of an immature GR-1+ CD11b+ population induces T cell suppression and Th2 polarization in sepsis
Matthew J. Delano et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Niche-to-niche migration of bone-marrow-derived cells
Rosandra N. Kaplan et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Bone marrow cells in the 'pre-metastatic niche': within bone and beyond
Rosandra N. Kaplan et al.
CANCER AND METASTASIS REVIEWS (2006)
Preparing the Soil: The premetastatic niche
Rosandra N. Kaplan et al.
CANCER RESEARCH (2006)
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Giovanna Gallina et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S-phase arrest, in human myeloma cells
Anke J. Roelofs et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The bisphosphonate zoledronic acid inhibits the development of plasmacytoma induced in BALB/c mice by intraperitoneal injection of pristane
F Avcu et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells
P Serafini et al.
CANCER RESEARCH (2004)
Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion
M Abe et al.
BLOOD (2004)
Expansion of myeloid immune suppressor Gr+CD11b+cells in tumor-bearing host directly promotes tumor angiogenesis
L Yang et al.
CANCER CELL (2004)
Transforming growth factor-beta in osteolytic breast cancer bone metastases
TA Guise et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2003)
HERG K+ channels activation during β1 integrin-mediated adhesion to fibronectin induces an up-regulation of αvβ3 integrin in the preosteoclastic leukemia cell line FLG 29.1
G Hofmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)